Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients

We have analysed the predictive and prognostic information in preoperatively collected serum levels of vascular endothelial growth factor (VEGF) and basic Fibroblast growth factor (bFGF) in patients clinically evaluated as operable non-small cell lung cancer (NSCLC). Fifty-eight patients with operable NSCLC were included. VEGF and bFGF levels in serum were analysed using enzyme linked immunosorbent assays (Quantikine(TM) human VEGF and Quantikine((TM)) HS human FGF basic, R&D Systems). Univariate analysis demonstrated that tumour volume, platelet counts. VEGF and bFGF were significant prognostic factors, However, only bFGF remained significant in the multivariate analysis (P=0.014). Significant correlation's were demonstrated between VEGF levels and tumour volume (r = 0.33: P = 0.012) and platelet count (r = 0.43; P = 0.001). bFGF levels correlated significant with recurrent disease (r = 0.34; P = 0.01), platelet count (r = 0.53. P < 0.001) and performance status (r = 0.29 P = 0.029). Furthermore, bFGF levels and VEGF levels correlated significantly (r = 0.44, P < 0.001). We Conclude that elevated circulating angiogenic cytokines correlate with tumour volume, higher relapse risk and poorer survival in patients with operable non-small cell lung cancer. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.